Preparation of the serotonin transporter PET radiotracer 2-({2-[(dimethylamino) methyl] phenyl} thio)-5-[18F] fluoroaniline (4-[18F] ADAM): probing synthetic and …

SM Sephton, X Zhou, S Thompson, FI Aigbirhio - Synthesis, 2019 - thieme-connect.com
Serotonin transporters (SERTs) are involved in regulating the concentration of synaptic
serotonin and present a good target for many neurologic and psychiatric disorder drugs …

Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects

W Robeson, V Dhawan, A Belakhlef, Y Ma… - Journal of Nuclear …, 2003 - Soc Nuclear Med
This study was designed to evaluate the radiation dosimetry in human subjects for a new
radiopharmaceutical, N-(3-18F-fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) …

Imaging Procedure and Clinical Studies of [18F]FP-CIT PET

C Sung, SJ Oh, JS Kim - Nuclear Medicine and Molecular Imaging, 2024 - Springer
Abstract N-3-[18F] fluoropropyl-2β-carbomethoxy-3β-4-iodophenyl nortropane ([18F] FP-
CIT) is a radiopharmaceutical for dopamine transporter (DAT) imaging using positron …

A practical route for synthesizing a PET ligand containing [18F] fluorobenzene using reaction of diphenyliodonium salt with [18F] F−

MR Zhang, K Kumata, K Suzuki - Tetrahedron Letters, 2007 - Elsevier
The aim of this study was to develop a practical route for preparing a fluorine-18 ([18F])
labelled ligand ([18F] 1) containing [18F] fluorobenzene ring by employing the reaction of …

[HTML][HTML] Advances in [18F]Trifluoromethylation Chemistry for PET Imaging

F Francis, F Wuest - Molecules, 2021 - mdpi.com
Positron emission tomography (PET) is a preclinical and clinical imaging technique
extensively used to study and visualize biological and physiological processes in vivo …

Quantitative analysis of 18F-FE-PE2I binding to the dopamine transporter in Parkinson's disease

P Fazio, P Svenningsson, A Forsberg… - Journal of Nuclear …, 2015 - Soc Nuclear Med
18 F-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β-(4′-methyl-phenyl) nortropane
(18 F-FE-PE2I) is a recently developed radioligand for in vivo quantification of the dopamine …

Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease

H Li, X Zhang, J Zhang - Int J Radiat Med Nucl Med, 2016 - ijrmnm.com
Parkinson disease (PD) is the second most common neurodegenerative disease. It is known
to be associated with age, hormonal imbalance, lifestyle exposures, and genetic factors, as …

Contamination of [18F] fallypride with carrier fluorine reduced with microwave labeling

M Ansari, J Clanton, R Kessler, R Baldwin - 2009 - Soc Nuclear Med
30 Objectives We previously reported process comparison of microwave and thermal
methods for synthesizing the dopamine D2 receptor tracer [18 F] fallypride. In this study we …

Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [68Ga] IPCAT-NOTA as an Imaging Agent for Dopamine Transporter

SS Farn, KW Chang, WC Lin, HM Yu… - Drug Design …, 2021 - Taylor & Francis
Introduction Novel radiotracer development for imaging dopamine transporters is a subject
of interest because although [99mTc] TRODAT-1,[123I] β-CIT, and [123I] FP-CIT are …

Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites

DR Elmaleh, AJ Fischman, TM Shoup… - The Journal of …, 1996 - search.proquest.com
Parkinson's disease is a progressive neurodegenerative disorder that is associated with the
loss of nerve terminals from specific brain areas, particularly in the caudate and putamen …